• Je něco špatně v tomto záznamu ?

Mitral Valve Replacement Using Subvalvular Apparatus: A Systematic Review and Meta-Analysis

WC. Hsieh, A. Aboud, BM. Henry, CD. Kan, M. Omara, J. Lindner, H. Kolesová

. 2020 ; 23 (3) : E385-E392. [pub] 20200601

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, metaanalýza, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012527

BACKGROUND: To assess clinical outcomes among participants undergoing mitral valve replacement with preservation of subvalvular apparatus. METHODS: Electronic databases, including PubMed, Embase, Science Direct, World of Science, Scopus, Biosis, SciElo and Cochrane library, were probed using an extensive search strategy. Studies that reported at least one clinical outcome, such as morbidity, mortality, early 30-day mortality, myocardial failure, survival, late cerebrovascular events, length of stay, or major operative complications (stroke, prolonged ventilation, and reoperation for bleeding, renal failure, and sternal infection) were considered for inclusion. Data was extracted and pooled into a meta-analysis in RevMan (version 5.3) using a random-effects model. RESULTS: A total of 21 studies with 5,106 participants (age range: 27.3-69.2 years) were included in this meta-analysis. Preservation of the subvalvular apparatus during MVR significantly reduces the risk of long-term mortality (OR: 0.46; 95% CI: 0.33-0.64), but not early mortality (OR: 0.76; 95% CI: 0.12-4.93). No significant difference ejection fraction was observed (SMD: 0.10; 95% CI: -0.44-0.64). Similarly, there was no significant difference in the risk of stroke, renal failure, and pneumonia between C-MVR and in the control group. CONCLUSION: MVR with the preservation of subvalvular apparatus improves clinical outcomes, such as long-term mortality, hospital length of stay, pneumonia, and bleeding. There is no significant difference in the risk of stroke, renal failure, or ICU length of stay. However, there is very limited data available with respect to bleeding, sepsis, and nosocomial infections.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012527
003      
CZ-PrNML
005      
20210507104618.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1532/hsf.2659 $2 doi
035    __
$a (PubMed)32524988
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hsieh, Wan Chin $u First Faculty of Medicine, Charles University, Prague, Czech Republic; 2nd Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
245    10
$a Mitral Valve Replacement Using Subvalvular Apparatus: A Systematic Review and Meta-Analysis / $c WC. Hsieh, A. Aboud, BM. Henry, CD. Kan, M. Omara, J. Lindner, H. Kolesová
520    9_
$a BACKGROUND: To assess clinical outcomes among participants undergoing mitral valve replacement with preservation of subvalvular apparatus. METHODS: Electronic databases, including PubMed, Embase, Science Direct, World of Science, Scopus, Biosis, SciElo and Cochrane library, were probed using an extensive search strategy. Studies that reported at least one clinical outcome, such as morbidity, mortality, early 30-day mortality, myocardial failure, survival, late cerebrovascular events, length of stay, or major operative complications (stroke, prolonged ventilation, and reoperation for bleeding, renal failure, and sternal infection) were considered for inclusion. Data was extracted and pooled into a meta-analysis in RevMan (version 5.3) using a random-effects model. RESULTS: A total of 21 studies with 5,106 participants (age range: 27.3-69.2 years) were included in this meta-analysis. Preservation of the subvalvular apparatus during MVR significantly reduces the risk of long-term mortality (OR: 0.46; 95% CI: 0.33-0.64), but not early mortality (OR: 0.76; 95% CI: 0.12-4.93). No significant difference ejection fraction was observed (SMD: 0.10; 95% CI: -0.44-0.64). Similarly, there was no significant difference in the risk of stroke, renal failure, and pneumonia between C-MVR and in the control group. CONCLUSION: MVR with the preservation of subvalvular apparatus improves clinical outcomes, such as long-term mortality, hospital length of stay, pneumonia, and bleeding. There is no significant difference in the risk of stroke, renal failure, or ICU length of stay. However, there is very limited data available with respect to bleeding, sepsis, and nosocomial infections.
650    _2
$a design vybavení $7 D004867
650    _2
$a chirurgická náhrada chlopně $x přístrojové vybavení $7 D019918
650    _2
$a lidé $7 D006801
650    _2
$a mitrální chlopeň $x chirurgie $7 D008943
650    _2
$a mitrální insuficience $x chirurgie $7 D008944
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a systematický přehled $7 D000078182
700    1_
$a Aboud, Anas $u Department of Cardiac and Thoracic Vascular Surgery, University of Schleswig-Holstein, Lübeck Campus, Lübeck, Germany
700    1_
$a Henry, Brandon Michael $u Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
700    1_
$a Kan, Chung Dann $u Division of Cardiovascular Surgery, Department of Surgery, National Cheng Kung University Hospital, Tainan, Taiwan
700    1_
$a Omara, Mohamed $u Department of Thoracic and Cardiovascular Surgery, Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
700    1_
$a Lindner, Jaroslav $u 2nd Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Kolesová, Hana $u Institute of Anatomy, First Faculty of Medicine, Charles University
773    0_
$w MED00181085 $t The heart surgery forum $x 1522-6662 $g Roč. 23, č. 3 (2020), s. E385-E392
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32524988 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104617 $b ABA008
999    __
$a ok $b bmc $g 1650816 $s 1132906
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 23 $c 3 $d E385-E392 $e 20200601 $i 1522-6662 $m The heart surgery forum $n Heart Surg Forum $x MED00181085
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace